Barrett Katz

Chief Medical Officer, Viridian Therapeutics, Inc.\DE.

Companies

Viridian Therapeutics, Inc.\DEChief Medical Officer Jan 21, 2021 to Feb 10, 2023¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jan 17, 2023Sold 24,853 shares at $37.21 of Viridian Therapeutics, Inc.\DE²
Jan 17, 2023Exercised options 24,853 shares at $23.03 of Viridian Therapeutics, Inc.\DE²
Jan 13, 2023Sold 4,147 shares at $37.01 of Viridian Therapeutics, Inc.\DE²
Jan 13, 2023Exercised options 4,147 shares at $23.03 of Viridian Therapeutics, Inc.\DE²
Jan 10, 2023Sold 47,377 shares at $35.30 of Viridian Therapeutics, Inc.\DE³
Jan 10, 2023Exercised options 47,377 shares at $23.03 of Viridian Therapeutics, Inc.\DE³
Jan 9, 2023Sold 12,623 shares at $33.04 of Viridian Therapeutics, Inc.\DE³
Jan 9, 2023Exercised options 12,623 shares at $23.03 of Viridian Therapeutics, Inc.\DE³

The numbers on this page point here. Each one links to the record it came from.